Dr.Ramesh Cardiac & Multispeciality Hospital

Name :

Dr.Ramesh Cardiac & Multispeciality Hospital

Address  :

Ring Road

Town  :

Vijayawada

State  :

Uttar Pradesh

Country  :

INDIA

Post Code:

520008

Phone  :

91 866 2470283

Fax  :

91 866 2473554

Web URL  :

Specialization
  • Angiography.
  • Cardiology
  • General Medicine
  • General Surgeon
  • Neurologist
Facilities

ICCU Beds : 70

Total Number Of Beds : 200

Speciality Type :

Other Facilities

  • X-Ray

Description

DR RAMESH CARDIAC AND MULTISPECIALITY HOSPITAL is located in the heart of the city of Vijayawada abetting the NH 5 the hospital is five storied palatial twin building in the sprawling greens of Loyola Campus

It was launched with ICCU amp Noninvasive Lab first of its kind in coastal Andhra Pradesh in 1988 August 15th His Excellency DrShankar Dayal Sharma inaugurated the ultra modern digital Cathlab Operation Theater with global standards on 21st October 1996

The multispeciality has the departments CardiologyNeurology Nephrology Diabetology General Medicine General Surgery Dr PRamesh Babu the founder of the hospital is the Chief Cardiologist and Managing Director of the Organisation has been trained from AIIMS one of the most prestigious medical institutes in India DrRamesh Babu wanted to dedicate his services to his hometown Vijayawada Andhra Pradesh

The Hospital has 200 beds and 70 Intensive Care beds for Cardiology and Neurology Four Operation Theatres one Phillips Flat panel Digital Cath Lab with Stent Boost Technology and DSADigital Subtraction Angiography and Poly Skops Multiphos 10 High Frequency XRay equipment of Siemons
Apollo Hospitals to open new unit in Ahmedabad

National healthcare chain Apollo Group of Hospitals after deciding to increase thenumber of beds in their Gandhinagar setup have now planned to come up with one more unit in Ahmedabad The existing Apollo Hospital City Centre near Parimal Garden in Ahmedabad will be shifted to a nearby location and a new hospital specialising in heart care will be b... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More